1. Home
  2. RNXT vs NBY Comparison

RNXT vs NBY Comparison

Compare RNXT & NBY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo RenovoRx Inc.

RNXT

RenovoRx Inc.

HOLD

Current Price

$0.89

Market Cap

37.0M

Sector

Health Care

ML Signal

HOLD

Logo NovaBay Pharmaceuticals Inc.

NBY

NovaBay Pharmaceuticals Inc.

HOLD

Current Price

$1.95

Market Cap

31.6M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
RNXT
NBY
Founded
2012
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
37.0M
31.6M
IPO Year
2021
2007

Fundamental Metrics

Financial Performance
Metric
RNXT
NBY
Price
$0.89
$1.95
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$8.25
N/A
AVG Volume (30 Days)
311.0K
608.2K
Earning Date
05-14-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
20.00
35.42
EPS
N/A
0.76
Revenue
$1,123,000.00
$370,000.00
Revenue This Year
$194.66
N/A
Revenue Next Year
$279.78
N/A
P/E Ratio
N/A
$2.57
Revenue Growth
2511.63
N/A
52 Week Low
$0.70
$0.43
52 Week High
$1.45
$19.95

Technical Indicators

Market Signals
Indicator
RNXT
NBY
Relative Strength Index (RSI) 48.40 57.82
Support Level $0.89 $1.01
Resistance Level $1.07 $2.52
Average True Range (ATR) 0.07 0.26
MACD 0.01 0.11
Stochastic Oscillator 54.09 96.45

Price Performance

Historical Comparison
RNXT
NBY

About RNXT RenovoRx Inc.

RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.

About NBY NovaBay Pharmaceuticals Inc.

NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare, wound care, and skin care products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material, including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease.

Share on Social Networks: